GSK3B and glioma: To further explore the pathway through which miR-29a/b/c suppress glioma cell proliferation, we focused on the crucial effectors downstream of TRAF4, including AKT, GSK-3β, c-Myc, and the G1/S-phase checkpoint regulator cyclin D1.